Kringle Pharma, Inc. (4884.T)

JPY 814.0

(-0.73%)

Annual Income Statements

(In JPY)
Breakdown 2023 2022 2021 2020 2019
Revenue 69.25 Million 391.82 Million 289.75 Million 467.61 Million -
Cost of Revenue - 88.41 Million 71.59 Million - -
Gross Profit 69.25 Million 303.41 Million 218.15 Million 467.61 Million -
Operating Expenses 958.01 Million 729.58 Million 576.03 Million 639.21 Million 371.74 Million
Selling, General and Administrative Expenses - 196 Million 178 Million 150 Million 105.94 Million
Research and Development Expenses 716.79 Million 533 Million 398 Million 489 Million 265.79 Million
Other Expenses 241.22 Million 82.08 Million 65.84 Million 63.35 Million -
Cost and Expenses 958.01 Million 817.99 Million 647.63 Million 639.21 Million 371.74 Million
Operating Income -888.76 Million -426.16 Million -357.88 Million -171.6 Million -371.74 Million
Interest Expense - - 6.6 Million - -
Income Tax Expense 1.49 Million 1.49 Million 1.49 Million 1.49 Million 420 Thousand
Earnings before Tax -852.66 Million -330.33 Million -299.67 Million -116.34 Million -301.63 Million
Net Income -854.15 Million -331.82 Million -301.16 Million -117.83 Million -302.05 Million
Earnings Per Share Basic -158.46 -68.33 -72.51 -106.70 -71.45
Earnings Per Share Diluted -158.46 -68.33 -72.51 -106.70 -71.45
Weighted Average Shares Outstanding 5.39 Million 4.85 Million 4.15 Million 1.1 Million 4.22 Million
Weighted Average Shares Outstanding (Diluted) 5.39 Million 4.85 Million 4.15 Million 1.1 Million 4.22 Million
Gross Margin 1.00 0.77 0.75 1.00 -
EBIT Margin -12.83 -1.09 -1.24 -0.37 -
Profit Margin -12.33 -0.85 -1.04 -0.25 -
EBITDA -888.76 Million - -299.67 Million - -
Earnings Before Tax Margin -12.83 -1.09 -1.24 -0.37 -

Income Statement Charts